AGENDA

The 1st Annual Ontario Translational Research Network Forum

Friday, October 3RD, 2008

MaRS Discovery District, Auditorium A,B,C

101 College Street, South Tower, Toronto

Forum Purpose:

The purpose of the forum is to inform Researchers of ethical and legal issues, best practices and current initiatives in bio specimen research. This will also provide the attendees an educational as well as networking opportunity.

Time TitleSpeaker

9:30 – 10:30 a.m.Closed OTRN Executive Meeting

Location: Green Room

10:00 – 10:30 a.m.REGISTRATION (Light Breakfast Served)

10:30 - 10:40 a.m.Welcome and Introduction to OTRNChair: Malcolm Moore

Dr.Malcolm Moore: Director, Bras Drug Development Program,

Princess Margaret Hospital

10:40 - 10:50 a.m.Opening RemarksBob Phillips

Dr. Bob Phillips: Deputy Director, Ontario Institute of
Cancer Research

SESSION 1Ethical, Legal & Policy Issues in Biospecimen ResearchChair: Lillian Siu

10:50 – 11:10 a.m.Implications of Biospecimen Research: Ethical PerspectiveRon Heslegrave

Dr. Ron Heslegrave: Chair, Ontario Cancer Research Ethics Board &

Research Ethics Board, University Health Network

11:10 – 11:30 a.m.Implications of Biospecimen Research: Public PerspectiveDeborah Collyar

Deborah Collyar: President, Patients Advocates In Research

11:30 – 11:50 a.m.Implications of Biospecimen Research: Investigator PerspectiveAmitOza

Dr. Amit Oza: Professor of Medicine, Univ. of Toronto,

Co-director, Drug Development Program, PMH

11:50 a.m.– 12:20 p.m.Panel Discussion:

Deborah Collyar - Ron Heslegrave – Amit Oza

12:20 – 1:00 p.m.LUNCH

Time TitleSpeaker

SESSION 2:Current Initiatives in Biospecimen Banking:Chair: David LeBrun

Challenges, Successes and Lessons Learned

1:00 - 1:20 p.m.National Cancer Institute of Canada Tumor BankMing Tsao

Dr. Ming Tsao, Pathology, University Health Network

1:20 – 1:40 p.m.Ontario Tumor Bank Brent Zanke

Dr. Brent Zanke, Vice-President, OICR;

Director, Ontario Tumor Bank

1:40 – 2:00 p.m.PMH Tumor BankPatricia Shaw

Dr. Patricia Shaw – Director, PMH/ UHN Biobank

2:00 – 2:15 p.m.Panel Discussion:

Patricia Shaw - Ming Tsao – Brent Zanke

2:15 – 2:30 p.m.REFRESHMENT BREAK

SESSION 3:Challenges and Opportunities in BiospecimenChair: Eric Winquist
Research

2:30 – 2:50 p.m.NCI Best Practices for Biospecimen ResourcesCarolyn Compton

Why do we need Biospecimen Best Practices?

Dr. Carolyn Compton: Director, Office of Biorepositories

& Biospecimen Research - National Cancer Institute

2:50 – 3:10 p.m.Integrating Biospecimen Collection into Clinical ResearchJanet Dancey

Dr. Janet Dancey: Director, High Content Clinical Trials Program,

Ontario Institute for Cancer Research

3:10 – 3:30 p.m.Economic Issues in Biospecimen ResearchTerrence Sills

Ontario Cancer Biomarker Network

3:30 – 4:00 p.m.Panel Discussion:

Carolyn Compton – Janet Dancey – Terrence Sills

4:00 p.m.Closing Remarks Malcolm Moore

***************************************

1